Prothena Corp PLC (PRTA)

56.23
NASDAQ : Health Care
Prev Close 56.23
Day Low/High 0.00 / 0.00
52 Wk Low/High 33.53 / 68.18
Avg Volume 307.70K
Exchange NASDAQ
Shares Outstanding 38.02M
Market Cap 2.12B
EPS -4.70
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Prothena Raises $155.3M to Bring Anti-Organ Failure Drug to Market

Prothena Raises $155.3M to Bring Anti-Organ Failure Drug to Market

The biotech company plans to commercialize its treatment for AL amyloidosis, a disease that causes protein to build up in the blood.

Biotech Premarket Movers: Karyopharm, Lexicon, Prothena

Biotech Premarket Movers: Karyopharm, Lexicon, Prothena

Karyopharm Therapeutics falls 18%; Lexicon rises on drug approval.

First-In-Human Assessment Of PRX002, Prothena's Anti-Alpha Synuclein Antibody For Parkinson's Disease, Published In Movement Disorders Journal

First-In-Human Assessment Of PRX002, Prothena's Anti-Alpha Synuclein Antibody For Parkinson's Disease, Published In Movement Disorders Journal

Data Previously Presented in 2015 at 19th International Congress of Parkinson's Disease and Movement Disorders

Prothena (PRTA) Is Today's Perilous Reversal Stock

Prothena (PRTA) Is Today's Perilous Reversal Stock

Trade-Ideas LLC identified Prothena (PRTA) as a "perilous reversal" (up big yesterday but down big today) candidate

Prothena (PRTA) Flagged As Strong On High Volume

Prothena (PRTA) Flagged As Strong On High Volume

Trade-Ideas LLC identified Prothena (PRTA) as a strong on high relative volume candidate